4/25
08:10 am
fblg
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids [Yahoo! Finance]
Medium
Report
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids [Yahoo! Finance]
4/25
08:00 am
fblg
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
Medium
Report
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
4/11
09:31 am
fblg
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
Low
Report
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
4/4
09:31 am
fblg
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
Low
Report
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
3/28
09:31 am
fblg
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
Medium
Report
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus
3/19
09:31 am
fblg
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
High
Report
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
3/19
09:31 am
fblg
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
High
Report
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
3/13
09:31 am
fblg
FibroBiologics to Present at Advanced Wound Care Summit USA
Medium
Report
FibroBiologics to Present at Advanced Wound Care Summit USA
3/6
09:31 am
fblg
FibroBiologics Appoints Ruben A. Garcia as General Counsel
Medium
Report
FibroBiologics Appoints Ruben A. Garcia as General Counsel
2/29
05:44 pm
fblg
FibroBiologics Files 2023 Form 10-K Annual Report
Low
Report
FibroBiologics Files 2023 Form 10-K Annual Report
2/20
09:31 am
fblg
FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum
Medium
Report
FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum
2/13
09:31 am
fblg
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
High
Report
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
2/8
09:31 am
fblg
FibroBiologics Announces Three United States Patents for Fibroblast Technology
High
Report
FibroBiologics Announces Three United States Patents for Fibroblast Technology
2/6
09:31 am
fblg
FibroBiologics Announces Three Japanese Patents on Fibroblast Technology
High
Report
FibroBiologics Announces Three Japanese Patents on Fibroblast Technology
1/31
10:00 am
fblg
FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG
Medium
Report
FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG